THRD — Third Harmonic Bio Income Statement
0.000.00%
Last trade - 00:00- $242.79m
- -$28.82m
Annual income statement for Third Harmonic Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 11.1 | 19 | 37.7 | 44 | 58.9 |
| Operating Profit | -11.1 | -19 | -37.7 | -44 | -58.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.8 | -29.6 | -35.2 | -30.8 | -45.5 |
| Net Income After Taxes | -12.8 | -29.6 | -35.2 | -30.8 | -45.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.8 | -29.6 | -35.2 | -30.8 | -45.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.8 | -29.6 | -35.2 | -30.8 | -45.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.331 | -0.765 | -0.893 | -0.777 | -1.09 |
| Dividends per Share |